当前位置:主页 > 医学论文 > 中医论文 >

补肾安胎冲剂对复发性流产小鼠蜕膜组织VEGF、VEGFR2、RAS、MAPK蛋白表达影响的实验研究

发布时间:2018-05-27 04:06

  本文选题:补肾安胎冲剂 + 复发性流产 ; 参考:《安徽中医药大学》2016年硕士论文


【摘要】:目的:通过以VEGF信号通路为切入点,观察研究补肾安胎冲剂对复发性流产模型小鼠子宫及胚胎发育情况,胚胎丢失率及检测蜕膜组织VEGF、VEGFR2、RAS、MAPK蛋白表达,明确补肾健脾中药治疗RSA在妊娠胚胎的血管重铸方面的作用机理,为中医药补肾安胎冲剂治疗RSA提供一定的理论依据。方法:以雌鼠CBA/J与雄鼠DBA/2建立复发性流产小鼠模型,雌鼠CBA/J与雄鼠BALB/c建立正常妊娠小鼠模型,雌雄鼠按照2∶1合笼交配,适应性喂养1周后。造模的妊娠小鼠共计60只,分为六组:正常妊娠组,复发性流产模型妊娠组,西药治疗组,中药低剂量治疗组,中药中剂量治疗组,中药高剂量治疗组。从检测出小鼠妊娠的第1天算起,予以灌胃处理:复发性流产模型妊娠组即是模型组,予胃中灌入稀释后的蒸馏水;西药治疗组饲喂稀释的黄体酮胶囊,黄体酮胶囊的剂量为0.4mg/kg.d;中药低剂量治疗组即是补肾安胎冲剂低剂量组,饲喂稀释后的补肾安胎冲剂,冲剂的剂量为3.9g/kg.d;中药中剂量治疗组即是补肾安胎冲剂中剂量组,予以喂入稀释后的补肾安胎冲剂,冲剂的剂量为11.7g/kg.d;中药高剂量治疗组即是补肾安胎冲剂高剂量组,饲喂稀释后的补肾安胎冲剂,冲剂的剂量为35.1g/kg.d,连续给药共计15天。小鼠末次给药24h后,予以处死,取出子宫,剖视观察胚胎发育情况,计算胚胎丢失率,用Western blot法检测妊娠小鼠蜕膜组织中VEGF、VEGFR2、RAS、MAPK的蛋白表达水平。结果:1.剖视观察见正常妊娠组小鼠子宫及胚胎发育良好,颜色呈淡红色,形态如串珠状,质地大小较均匀,宫腔内未见显著瘀血之处,子宫的着床点未见明显的出血。模型组妊娠小鼠子宫及胚胎发育较差,颜色呈黑褐色,形态呈竹节样改变,质地不均匀,宫腔内可见明显的瘀血点,或在胚胎的着床点处见到部分或完全消失的胚胎组织。西药组、补肾安胎冲剂低、中、高剂量组子宫及胚胎质地较为均匀,呈淡红色,宫腔内未见明显的出血点,胚胎发育较好。2.与正常妊娠组相比较,模型对照组胚胎丢失率显著上升(P0.05)。与复发性流产模型妊娠组相比较,西药治疗组、补肾安胎冲剂中剂量、补肾安胎冲剂高剂量组显著降低,有统计学差异(P0.05)。3.与正常妊娠组比较,复发性流产模型妊娠组VEGF表达含量显著降低(P0.01)。与复发性流产模型妊娠组比较,西药治疗组、中药低、中、高剂量治疗组VEGF表达显然升高(P0.01);与西药治疗组、中药低剂量治疗组、中药中剂量治疗组比较,中药高剂量治疗组的VEGF表达含量显著升高(P0.05)。4.与正常妊娠组比较,复发性流产模型妊娠组VEGFR2表达含量显著降低(P0.01)。与复发性流产模型妊娠组比较,西药治疗组、中药低、中、高剂量治疗组VEGFR2表达显然升高(P0.01);与西药治疗组、中药低剂量组、中药中剂量治疗组比较,中药高剂量治疗组的VEGFR2表达含量显著升高(P0.05)。5.与正常妊娠组比较,复发性流产模型妊娠组RAS表达含量显著降低(P0.01)。与复发性流产模型妊娠组比较,西药治疗组、中药低、中、高剂量治疗组RAS表达显然升高(P0.01);与西药治疗组、中药低剂量组、中药中剂量治疗组比较,中药高剂量治疗组的RAS表达含量显著升高(P0.05)。6.与正常妊娠组比较,复发性流产模型妊娠组MAPK表达含量显著降低(P0.01)。与复发性流产模型妊娠组比较,西药治疗组、中药低、中、高剂量治疗组MAPK表达显然升高(P0.01);与西药治疗组、中药低剂量组、中药中剂量治疗组比较,中药高剂量治疗组的MAPK表达含量显著升高(P0.05)。结论:1、补肾安胎冲剂对复发性流产小鼠妊娠子宫和胚胎发育可能有一定的促进作用。2、补肾安胎冲剂能显著降低复发性流产小鼠模型的胚胎丢失率,达到保胎的疗效。3、VEGF、VEGFR2、RAS、MAPK的蛋白印迹检测结果,指出补肾安胎冲剂治疗复发性流产发挥有效疗效的作用机制可能是上调VEGF信号通路下游的RAS、MAPK蛋白表达水平,同时提高复发性流产小鼠蜕膜组织的VEGF、VEGFR2蛋白表达水平,改善复发性流产模型小鼠母胎界面血管生成,维持妊娠,有效降低了复发性流产小鼠的胚胎丢失率。
[Abstract]:Objective: To observe the development of uterus and embryo, the rate of embryo loss and the expression of VEGF, VEGFR2, RAS and MAPK protein in the decidua tissue, by using the VEGF signal pathway as the breakthrough point, and to clarify the mechanism of the effect of the Chinese herbal medicine for invigorating the kidney and invigorating the spleen on the vascular recasting of pregnancy induced pregnancy. To provide a certain theoretical basis for the treatment of RSA by Bushen Antai granule. Methods: a mouse model of recurrent abortion was established in the female rat CBA/J and the male rat DBA/2. The female rat CBA/J and the male rat BALB/c established the normal pregnancy mice model. The male and female mice were copulated according to the 2: 1 cage, and after 1 weeks of adaptive feeding. The model pregnant mice were divided into six groups: normal pregnancy group, The recurrent abortion model pregnancy group, the western medicine treatment group, the traditional Chinese medicine low dose treatment group, the medium dose treatment group, the high dose Chinese medicine treatment group. From the first days of the pregnancy test, the recurrent abortion model pregnancy group was the model group, the diluted distilled water was injected into the stomach, and the western medicine treatment group was fed the diluted yellow. The dose of somatic ketone capsule, the dose of progesterone capsule is 0.4mg/kg.d, the low dose treatment group of traditional Chinese medicine is the low dose group of Bushen Antai granule, and the dosage of the diluted kidney and Antai granule is 3.9g/kg.d, the dosage group in the middle dose of Chinese traditional medicine is the dose group of the tonifying kidney antire granules, and the dosage of the decoction is given after the dilution. 11.7g/kg.d, the high dose group of traditional Chinese medicine was a high dose group of Bushen Antai granule, and the dosage of the diluted kidney and anfetus was 35.1g/kg.d, the dosage of the granule was 15 days. After the last dose of 24h, the mice were executed, the uterus was taken out, the embryo development situation was observed, the embryo loss rate was calculated, the pregnancy loss was detected by Western blot method. The pregnancy was detected by Western blot method. The protein expression level of VEGF, VEGFR2, RAS, MAPK in the rat Decidua Tissue. Results: 1. the uterus and embryo of the normal pregnancy group were well developed, the color of the uterus and the embryo were well developed, the color was light red, the shape was like the beads, the size of the texture was more uniform, the blood stasis of the uterus was not obvious in the uterus. The uterus and the uterus of the uterus were not obviously bleeding. The uterus of the model group of pregnancy mice and the uterus and the uterus and the uterus of the model group of pregnancy mice were not seen. The embryo development is poor, the color is black and brown, the shape is bamboo node change, the texture is uneven, the intrauterine obvious blood stasis is visible, or the embryo tissue which is partially or completely disappeared at the implantation point of the embryo. The western medicine group, the kidney and the high dose group of the uterus and the high dose group are more uniform, pale red, and the uterine cavity is not obvious. When compared with the normal pregnancy group, the embryo loss rate of the model control group was significantly higher than the normal pregnancy group (P0.05). Compared with the recurrent abortion model pregnancy group, the western medicine treatment group, the dosage of tonifying kidney anetin granule and the high dose group of Bushen antire granules were significantly reduced, and the difference was statistically significant (P0.05).3. was compared with the normal pregnancy group (P0.05). The expression of VEGF in the pregnant group with recurrent abortion was significantly decreased (P0.01). Compared with the recurrent abortion model pregnancy group, the expression of VEGF in the treatment group of Western medicine was obviously elevated (P0.01) in the low, middle and high dose treatment group. Compared with the western medicine treatment group, the low dose treatment group of traditional Chinese medicine, the dose treatment group in Chinese medicine, the VEGF expression in the high dose treatment group of Chinese medicine. Significantly higher (P0.05).4. compared with the normal pregnancy group, the expression of VEGFR2 in the recurrent abortion model group was significantly lower (P0.01). Compared with the recurrent abortion model pregnancy group, the western medicine treatment group, the low, middle, high dose treatment group of the Chinese medicine group obviously increased VEGFR2 expression (P0.01); with the western medicine treatment group, the low dose group of Chinese medicine, Chinese medicine medium dose treatment group Compared with the normal pregnancy group, the expression of VEGFR2 in the high dose treatment group was significantly higher (P0.05) than that in the normal pregnancy group. The expression of RAS in the recurrent abortion model group was significantly lower (P0.01). Compared with the recurrent abortion model pregnancy group, the western medicine treatment group, the low, middle and high dose treatment group of the western medicine treatment group obviously increased (P0.01), and the western medicine treatment group (P0.01); and the western medicine treatment group. Compared with the medium dose treatment group, the expression of RAS in the high dose treatment group of Chinese traditional medicine was significantly increased (P0.05).6. and the normal pregnancy group, the expression of MAPK in the recurrent abortion model group was significantly lower (P0.01). Compared with the recurrent abortion model pregnancy group, the Western Medicine treatment group, the Chinese medicine low, middle, high dose treatment group MAPK The expression of MAPK was obviously elevated (P0.01); compared with the western medicine treatment group, the low dose group of traditional Chinese medicine and the dose treatment group in the Chinese medicine, the expression of the high dose treatment group was significantly increased (P0.05). Conclusion: 1, the tonifying kidney Antai granule may have a certain promotion effect on the pregnancy uterus and embryo development of the recurrent abortion mice, and the tonifying kidney Antai granule can decrease significantly. The rate of embryo loss in mice with low recurrent abortion can achieve the curative effect of.3, VEGF, VEGFR2, RAS, MAPK, and points out that the mechanism of the effective effect of Bushen Antai granule in the treatment of recurrent abortion may be the up-regulation of the RAS, the expression of MAPK protein downstream of the VEGF signaling pathway and the increase of recurrent abortion in mice. The expression of VEGF and VEGFR2 protein in the decidual tissue improves the angiogenesis in the maternal fetal interface of recurrent abortion model mice and maintains pregnancy, which effectively reduces the rate of embryo loss in recurrent abortion mice.
【学位授予单位】:安徽中医药大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:R271

【相似文献】

相关期刊论文 前10条

1 王伟;殷小涛;田仁礼;阎瑾琦;高江平;于继云;;以VEGF及VEGFR2为靶位的抗肿瘤血管生成主动免疫治疗的研究进展[J];现代生物医学进展;2013年08期

2 孙玲;阴怀清;赵旭晶;房清丽;武师润;阴崇娟;;G-CSF对新生大鼠缺氧缺血性脑损伤后脑组织VEGF及VEGFR2的影响[J];中国药物与临床;2009年07期

3 马莉;苗乃周;艾庆燕;;ELV对青春期大鼠睾丸中VEGF与VEGFR2蛋白表达的影响[J];四川动物;2012年03期

4 熊程俏;李伟莉;;反复自然流产小鼠蜕膜VEGF、VEGFR2的表达及中药干预研究[J];中医药临床杂志;2013年02期

5 马莉;田宏;张洁;艾庆燕;苗乃周;王海旭;王丽蓉;邱曙东;张秋养;;VEGF、VEGFR2在青春期大鼠睾丸、附睾及附睾精子上的表达[J];中国组织化学与细胞化学杂志;2010年02期

6 李京红;方树友;宋波;;丁咯地尔对脑缺血再灌注大鼠VEGF与VEGFR2的影响[J];中风与神经疾病杂志;2005年05期

7 蒋晓东;戴鹏;宋大安;吴瑾;黎世秋;;HIF-1α、VEGF、VEGFR2在非小细胞肺癌组织中的表达及临床意义[J];临床肺科杂志;2011年03期

8 陈军;盛春泉;郑灿辉;李耀武;吕加国;张万年;周有骏;朱驹;;VEGFR2活性腔性质以及与抑制剂的结合模式研究[J];化学学报;2007年06期

9 夏一梦;王英伟;;乙醇对斑马鱼胚胎发育中VEGFR2基因表达的影响[J];临床麻醉学杂志;2009年07期

10 刘小虎;曾庆华;莫亚;唐春艳;谢礼丹;王毅;;健脾祛瘀法对血脂异常ApoE基因缺失小鼠色素上皮VEGF及VEGFR2的影响[J];国际眼科杂志;2012年06期

相关会议论文 前3条

1 黄品同;叶智敏;朱江;张旭;陈伟;吕琛;王尧;鄢曹鑫;;靶向VEGFR2微泡结合超声空化治疗结肠癌的实验研究[A];2011年浙江省超声医学学术年会论文汇编[C];2011年

2 韩晶;何佳佳;朱虹光;;EGFR,IGF-1R,Sox-2,Her-2,VEGFR1及VEGFR2在肝细胞肝癌中表达及临床意义[A];中华医学会病理学分会2010年学术年会日程及论文汇编[C];2010年

3 支琳琳;马晓春;;LPS对大鼠肾血管球内皮细胞VEGF、VEGFR2表达及通透性的影响[A];中华医学会第五次全国重症医学大会论文汇编[C];2011年

相关博士学位论文 前4条

1 卢亮;喹唑啉类VEGFR2抑制剂与双氧环Schiff碱类FabH抑制剂的设计、合成与构效关系研究[D];南京大学;2016年

2 张敏;靶向VEGF和VEGFR2的shRNA在抗肿瘤研究中的应用[D];中国协和医科大学;2006年

3 黄延林;恶性胶质瘤中EGFR和VEGFR2分子靶向联合治疗的实验研究[D];苏州大学;2010年

4 杨闯;抗VEGFR2-奥沙利铂免疫脂质体对结直肠癌靶向治疗的研究[D];重庆医科大学;2011年

相关硕士学位论文 前10条

1 李一鑫;胃癌中VEGF、VEGFR2表达的临床病理学意义及其对预后的影响[D];石河子大学;2015年

2 肖洋;靶向VEGFR2光声/超声双模态造影剂的制备及体外实验研究[D];重庆医科大学;2016年

3 曹晓梅;补肾安胎冲剂对复发性流产小鼠蜕膜组织VEGF、VEGFR2、RAS、MAPK蛋白表达影响的实验研究[D];安徽中医药大学;2016年

4 孙玲;rhG-CSF对新生大鼠缺氧缺血性脑损伤后脑组织VEGF及VEGFR2的影响[D];山西医科大学;2009年

5 陈姗;靶向EGFR及VEGFR2的siRNA治疗增强顺铂对非小细胞肺癌移植物的抗肿瘤作用[D];南方医科大学;2011年

6 王志坚;毛冬青甲素对大鼠脑缺血再灌注后VEGF和VEGFR2的表达及神经元再生的影响[D];福建医科大学;2011年

7 阳苑;非小细胞肺癌患者肺癌组织中VEGF、VEGFR2和ES蛋白表达及临床意义的研究[D];北京市结核病胸部肿瘤研究所;2012年

8 梁文龙;藤黄酸抑制VEGFR2活化在抗结直肠癌机制中的作用[D];广州医科大学;2013年

9 李茜;加味犀角地黄汤对CIA模型大鼠关节滑膜组织中VEGF、VEGFR2表达的影响[D];南京中医药大学;2010年

10 陈岩;微血管生成相关基因VEGFR2,EphrinB2在胃癌中的表达分析[D];天津医科大学;2013年



本文编号:1940340

资料下载
论文发表

本文链接:https://www.wllwen.com/zhongyixuelunwen/1940340.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户76f8f***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com